CRVO
CervoMed Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.43
−4.71%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.61
- Revenue estimate
- $50.0K
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.64
- EPS estimate
- -$0.80
- Revenue actual
- —
- Revenue estimate
- $50.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -0.3%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $22
- PT range
- $18 – $25
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.80 | -$0.64 | Beat 19.69% | — |
| May 18, 2026 | -$0.90 | -$0.86 | Beat 4.44% | — |
| Mar 13, 2026 | -$0.87 | -$0.88 | Miss -1.65% | $8.7K |
| Nov 7, 2025 | -$0.68 | -$0.84 | Miss -23.53% | $322.6K |
| Aug 8, 2025 | -$0.57 | -$0.70 | Miss -22.81% | $1.8M |
| Mar 17, 2025 | -$0.67 | -$0.80 | Miss -19.40% | $2.2M |
| Aug 9, 2024 | -$0.24 | -$0.27 | Miss -12.50% | $3.3M |
| May 14, 2024 | -$0.46 | -$0.41 | Beat 10.87% | $2.3M |
| Nov 13, 2023 | -$0.95 | -$0.70 | Beat 26.32% | $1.5M |
| May 15, 2023 | -$2.87 | -$3.01 | Miss -5.04% | $1.4M |
| Jun 30, 2021 | — | -$2.78 | — | — |
| Mar 31, 2021 | — | -$4.22 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026